Mitchel Sayare

Mitchel Sayare

Director/Miembro de la Junta en ALTIMMUNE, INC. .

Fortuna: 80 407 $ al 31/05/2026

78 años
Health Technology
Consumer Services
Commercial Services

Perfil

Mitchel B. Sayare is currently Director at Biotechnology Innovation Organization, Isabella Products, Inc., Advanced Aesthetic Technologies, Inc., and Independent Director at Altimmune, Inc. since 2025.
Former positions include Director at ImmuCell Corp., ImmunoGen, Inc. from 2009 to 2011, Theraclone Sciences, Inc., CymoGen Dx LLC, Boston IVF LLC, PharmAthene, Inc. from 2010 to 2011, Vice President-Development at Xenogen Corp.
from 1982 to 1985, Assistant Professor-Biophysics & Biochemistry at the University of Connecticut, and President at Apoptosis Technology, Inc. Education includes undergraduate studies at Ursinus College and a doctorate from Temple University School of Medicine.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
01/05/2026 26.363 ( 0,01 % ) 80 407 $ 31/05/2026

Cargos activos de Mitchel Sayare

EmpresasCargoInicio
ALTIMMUNE, INC. Director/Miembro de la Junta 12/08/2025
Director/Miembro de la Junta -
Director/Miembro de la Junta 04/06/2010
Director/Miembro de la Junta -

Antiguos cargos conocidos de Mitchel Sayare.

EmpresasCargoFin
IMMUNOGEN, INC. Director Ejecutivo 31/12/2009
Corporate Officer/Principal 01/01/1985
Apoptosis Technology, Inc.
Presidente -
Director/Miembro de la Junta -
Director/Miembro de la Junta -
Ver el detalle de la experiencia de Mitchel Sayare.

Formación de Mitchel Sayare.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

63

Relaciones de 1er grado

15

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas15

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Communications

Commercial Services

Consumer Services

Consumer Services

Health Services

Health Technology

Consumer Services

Health Technology

Health Technology

Apoptosis Technology, Inc.